Vitamin D (Sunshine Energy) and Health: Cutaneous Synthesis, Immune Effects, and Safe Supplementation

Vitamin D is a secosteroid hormone best known for its connection to “sunshine.” When ultraviolet B (UVB) radiation reaches the skin, it converts 7-dehydrocholesterol in the epidermis into previtamin D3, which isomerizes to cholecalciferol (vitamin D3). This vitamin D3 then undergoes two hydroxylations: first in the liver via 25-hydroxylase enzymes to form 25-hydroxyvitamin D [25(OH)D], the major circulating biomarker of vitamin D status; and second primarily in the kidney via 1-alpha-hydroxylase to generate calcitriol (1,25-dihydroxyvitamin D), the biologically active form that binds the vitamin D receptor (VDR) in many tissues.

Physiologically, vitamin D supports calcium and phosphate homeostasis. Calcitriol increases intestinal absorption of calcium and phosphate and promotes renal reabsorption, while also influencing bone remodeling by modulating osteoblast and osteoclast activity. Inadequate vitamin D impairs mineralization, contributing to osteomalacia in adults and rickets in children. Beyond skeletal health, vitamin D has immunomodulatory properties. VDR activation regulates gene transcription in immune cells, including dendritic cells, macrophages, and T lymphocytes, generally shifting toward a more regulated inflammatory response. Observational studies have linked low 25(OH)D levels with higher risk of certain infections and with outcomes in autoimmune conditions; however, causality and the magnitude of benefit from supplementation vary by population and baseline deficiency status.

Cardiometabolic and neuromuscular systems also intersect with vitamin D biology. Vitamin D deficiency is associated with muscle weakness and increased fall risk in older adults, partly through effects on muscle function (including calcium handling) and possibly through changes in neuromuscular signaling. In cardiovascular contexts, low vitamin D status has been associated with hypertension and adverse outcomes, though interventional trials show inconsistent results. Regarding cancer, vitamin D pathways (cell differentiation, proliferation, and apoptosis through VDR signaling) are biologically plausible, yet clinical trial outcomes have not consistently demonstrated clear risk reduction.

Testing is typically guided by risk factors and symptoms. Clinically, the most useful lab measure is serum 25(OH)D because it reflects both skin production and dietary intake with a longer half-life. Clinicians may also evaluate calcium, phosphate, parathyroid hormone (PTH), renal function, and alkaline phosphatase when deficiency or malabsorption is suspected.

Supplementation strategy depends on baseline levels, age, comorbidities, and whether the goal is repletion or maintenance. For individuals with confirmed deficiency, clinicians often use higher daily or intermittent dosing to achieve target 25(OH)D concentrations, followed by maintenance therapy. Particular caution is required in people with hypercalcemia, granulomatous diseases (e.g., sarcoidosis) that can increase extrarenal calcitriol production, certain lymphomas, advanced kidney disease, and those taking medications that affect calcium metabolism (such as thiazide diuretics) or bone agents. Vitamin D toxicity is uncommon but can occur with excessive dosing, leading to hypercalcemia, nephrolithiasis, renal impairment, nausea, constipation, and neurocognitive symptoms. Therefore, safety limits and lab monitoring are essential when using high-dose regimens.

Sun exposure itself is a double-edged factor. While UVB can raise vitamin D levels, it also increases risk of photoaging and skin cancers. Public health guidance emphasizes balancing vitamin D needs with skin cancer prevention by using sensible sun exposure, protective clothing, and sunscreen, especially during peak UV hours. Dietary sources include fatty fish (salmon, sardines), fortified dairy or plant milks, egg yolk, and fortified cereals; however, diet alone may not reliably correct deficiency in many individuals, particularly at higher latitudes or during seasons with limited UVB.

In practical terms, vitamin D adequacy is best approached as a risk-based clinical process: identify deficiency risk (older age, limited sun, darker skin pigmentation, obesity, malabsorption syndromes such as celiac disease or inflammatory bowel disease, chronic kidney disease, and certain medications), measure 25(OH)D when appropriate, and use evidence-based supplementation to normalize levels without overshooting. In parallel, maintaining safe behaviors for skin health and ensuring adequate calcium intake supports the skeletal and neuromuscular benefits of vitamin D.

Source: @calsivier